XBIOTECH INC.: income tax expense or benefit
Income tax expense or benefit for XBIOTECH INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All XBIOTECH INC. financial histories
What this measure means
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
Exact concept: us-gaap:IncomeTaxExpenseBenefit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2014-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 235,000 | USD | 2026-03-13 | 10-K · 0001171843-26-001561 |
| 2024-01-01 | 2024-12-31 | -32,000 | USD | 2026-03-13 | 10-K · 0001171843-26-001561 |
| 2023-01-01 | 2023-12-31 | 244,000 | USD | 2025-03-18 | 10-K · 0001171843-25-001527 |
| 2022-01-01 | 2022-12-31 | -688,000 | USD | 2024-03-15 | 10-K · 0001171843-24-001382 |
| 2021-01-01 | 2021-12-31 | -8,044,000 | USD | 2023-03-15 | 10-K · 0001171843-23-001705 |
| 2020-01-01 | 2020-12-31 | -1,606,000 | USD | 2022-03-15 | 10-K · 0001171843-22-001904 |
| 2019-01-01 | 2019-12-31 | 49,824,000 | USD | 2022-03-15 | 10-K · 0001171843-22-001904 |
| 2018-01-01 | 2018-12-31 | 0 | USD | 2021-03-16 | 10-K · 0001171843-21-001828 |
| 2017-01-01 | 2017-12-31 | 0 | USD | 2019-03-15 | 10-K/A · 0001171843-19-001758 |
| 2016-01-01 | 2016-12-31 | 0 | USD | 2019-03-15 | 10-K/A · 0001171843-19-001758 |
| 2015-01-01 | 2015-12-31 | 0 | USD | 2018-03-16 | 10-K · 0001171843-18-002043 |
| 2014-01-01 | 2014-12-31 | 0 | USD | 2017-03-16 | 10-K · 0001171843-17-001571 |
Related financial histories
- XBIOTECH INC.: total assets
- XBIOTECH INC.: total liabilities
- XBIOTECH INC.: stockholders equity
- XBIOTECH INC.: cash and cash equivalents
- XBIOTECH INC.: net income or loss
- XBIOTECH INC.: operating cash flow
- XBIOTECH INC.: capital expenditure payments
- XBIOTECH INC.: financing cash flow
- XBIOTECH INC.: investing cash flow
- XBIOTECH INC.: retained earnings or deficit
- XBIOTECH INC.: basic weighted-average shares
- XBIOTECH INC.: diluted weighted-average shares
- XBIOTECH INC.: basic earnings per share
- XBIOTECH INC.: diluted earnings per share
- XBIOTECH INC.: net property, plant and equipment
- XBIOTECH INC.: share-based compensation expense
- XBIOTECH INC.: operating income or loss
- XBIOTECH INC.: current assets
- XBIOTECH INC.: current liabilities
- XBIOTECH INC.: current accounts payable
- XBIOTECH INC.: net current accounts receivable
- XBIOTECH INC.: common-stock repurchase payments
- XBIOTECH INC.: operating expenses
- XBIOTECH INC.: gross profit
- XBIOTECH INC.: research and development expense
Inspect the source
- Entity
- XBIOTECH INC. / CIK 0001626878
- Captured
- 2026-09-21T17:21:01.627Z
- SEC response SHA-256
a6de11d2b8459cb01d6a091b52bdf85e4210871e91aeae1935f184db69bac658
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001626878.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))